Display Settings:

Format

Send to:

Choose Destination

    J Clin Invest. 1992 Jun;89(6):1902-7.

    A novel point mutation in the human insulin gene giving rise to hyperproinsulinemia (proinsulin Kyoto).

    Yano H, Kitano N, Morimoto M, Polonsky KS, Imura H, Seino Y.

    Department of Metabolism and Clinical Nutrition, Kyoto University Faculty of Medicine, Japan.

    We have identified a 65-yr-old nonobese Japanese man with diabetes mellitus, fasting hyperinsulinemia (150-300 pM), and a reduced fasting C-peptide/insulin molar ratio of 2.5-3.0. Fasting hyperinsulinemia was also found in his son and daughter. Analysis of insulin isolated from the serum of the proband and his son by reverse-phase high performance liquid chromatography revealed a minor peak coeluting with human insulin and a major peak of proinsulin-like materials. The insulin gene of the patient was amplified by the polymerase chain reaction and the products were sequenced. A novel point mutation was identified in which guanine was replaced by thymine. The substitution gives rise to a new HindIII recognition site and results in the amino acid replacement of leucine for arginine at position 65. These results indicate that the amino-acid replacement prevents recognition of the C-peptide-A chain dibasic protease and results in an elevation of proinsulin-like materials in the circulation. Furthermore, in this family the proinsulin-like materials is due to a biosynthetic defect, inherited as an autosomal dominant trait. Rapid detection of this mutation can be accomplished by HindIII restriction enzyme mapping of polymerase chain reaction-generated DNA, which enables us to facilitate the diagnosis and screening.

    PMID: 1601997 [PubMed - indexed for MEDLINE]

    PMCID: 295889

    Supplemental Content

    Click here to read Click here to read